StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.20−0.28 (-3.74%)

Close on Nov 17, 2026Market cap $515.08MP/E –Yield –

Immix Biopharma total assets

Total assets on the balance sheet at the end of each period.

Immix Biopharma's total assets was $239.11M at Jun 30, 2026. For fiscal 2025 it was $104.84M, up 356.9% from the year before. The highest annual figure on record is $104.84M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$104.84M+356.9%
FY2024Dec 31, 2024$22.95M+15.2%
FY2023Dec 31, 2023$19.93M+33.7%
FY2022Dec 31, 2022$14.91M-18.1%
FY2021Dec 31, 2021$18.19M+3271.4%
FY2020Dec 31, 2020$539.60K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$239.11M+1429.3%
Q1 FY2026Mar 31, 2026$95.82M+381.7%
Q4 FY2025Dec 31, 2025$104.84M+356.9%
Q3 FY2025Sep 30, 2025$20.08M-20.1%
Q2 FY2025Jun 30, 2025$15.64M-45.8%
Q1 FY2025Mar 31, 2025$19.89M-42.1%
Q4 FY2024Dec 31, 2024$22.95M+15.2%
Q3 FY2024Sep 30, 2024$25.14M+11.9%
Q2 FY2024Jun 30, 2024$28.84M+85.2%
Q1 FY2024Mar 31, 2024$34.35M+160.0%
Q4 FY2023Dec 31, 2023$19.93M+33.7%
Q3 FY2023Sep 30, 2023$22.47M+29.2%
Q2 FY2023Jun 30, 2023$15.57M-18.4%
Q1 FY2023Mar 31, 2023$13.21M-34.0%
Q4 FY2022Dec 31, 2022$14.91M-18.1%
Q3 FY2022Sep 30, 2022$17.40M+3123.7%
Q2 FY2022Jun 30, 2022$19.09M–
Q1 FY2022Mar 31, 2022$20.02M–
Q4 FY2021Dec 31, 2021$18.19M–
Q4 FY2020Dec 31, 2020$539.60K–

More Immix Biopharma figures

See a number that looks wrong?